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The antioxidant potentials of a total ethanolic extract of Hypericum perforatum (TE) and fractions were evaluated and correlated
with their phenolic contents. The extracts were fully characterised by HPLC–DAD–MS–MS. Kaempferol 3-rutinoside and rutin-
acetyl were identified for the first time in TE extracts. The free radical-scavenging properties of TE (EC50¼ 21 lg dwb/ml) and
fractions were studied using DPPH. Fractions containing flavonoids and/or caffeoylquinic acids were found to be the main con-
tributors to the free radical-scavenging activity of the TE. Lipid peroxidation, induced with ascorbate/Fe2þ, was significantly re-
duced in the presence of the TE (EC50¼ 26 lg dwb/ml) and fractions containing flavonoids and/or caffeoylquinic acids. The fraction
containing flavonoid aglycones was found to be responsible for a major part of the TE protection against lipid peroxidation.
Hypericins and hyperforins made no significant contributions to the antioxidant properties of TE. Human consumption of H.
perforatum extract or fractions could be beneficial.
 2004 Elsevier Ltd. All rights reserved.
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Reactive oxygen species (ROS) are generated by
many redox processes that normally occur in the me-
tabolism of aerobic cells. These species are highly reac-
tive and harmful to the cells. If not eliminated, ROS can
damage important molecules, such as proteins, DNA,
and lipids. Cells express several defence mechanisms,
including antioxidant enzymes and nonenzymatic com-
pounds, that help prevent the damaging effects of ROS
(Ben-Yoseph, Boxer, & Ross, 1996; Fridovich, 1997).
However, these endogenous systems are often in suffi-
cient for complete scavenging of ROS. Their excess hasAbbreviations: BHT, butylated hydroxytoluene; DPPH, 1,
1-diphen- yl-2-picrylhydrazyl; dwb, dry weight biomass; MDA, mal-
ondialdehyde; TBA, thiobarbituric acid; TBARS, thiobarbituric acid-
reactive species; TE, Hypericum perforatum total ethanolic extract.
* Corresponding author. Tel.: +351-253-604318; fax: +351-253-
678980.
E-mail address: acpdias@bio.uminho.pt (A.C.P. Dias).
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doi:10.1016/j.foodchem.2004.03.049been implicated in the development of chronic diseases,
such as cancer, arteriosclerosis and rheumatism (Halli-
well, 1996, 1999). Oxidative stress can also play an im-
portant role in the development of neurodegenerative
disorders, such as Alzheimer’s and Parkinson’s diseases
(Behl & Mosmann, 2002; Foy, Passmore, Vahidassr,
Young, & Lawson, 1999).
There is an increasing interest in natural antioxidants,
namely phenols, present in medicinal and dietary plants,
that might help prevent oxidative damage (Gardner,
White, McPhail, & Duthie, 2000; Halliwell, 1996, 1999;
Youdim, Spencer, Schroeter, & Rice-Evans, 2002;
Zheng & Wang, 2001). In situations of increased free
radical generation the reinforcement of endogenous
antioxidants via intake of dietary antioxidants may be of
particular importance in attenuating the cumulative ef-
fects of oxidatively damaged molecules.
In recent years, the consumption of Hypericum per-
foratum (St. John’s wort)-derived products has increased
dramatically and presently it is one of the most
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& Morgan, 2000). The commercially available H. per-
foratum derived products include sophisticated phyto-
pharmaceuticals and nutraceuticals, teas, tinctures,
juices and oily macerates (Gaedcke, 2003). Also, several
brands of common food products, such as bever-
ages and yoghurts, include St John’s wort extracts as
additives.
H. perforatum has a wide range of medicinal appli-
cations, including skin wounds, eczema, burns, diseases
of the alimentary tract and psychological disorders.
Nowadays, its use in the treatment of mild to moderate
depression has become prominent (Butterweck, 2003; Di
Carlo, Borrelli, Ernst, & Izzo, 2001; Erdelmeier, Koch,
& Hoerr, 2000). Numerous papers have been published
concerning these aspects and several recent reviews can
be pointed out (Agostinis, Vantieghem, Merlevede, & de
Witte, 2002; Butterweck, 2003; Di Carlo et al., 2001;
Erdelmeier et al., 2000; Prince et al., 2001). In spite of
this intense research activity, the antioxidant potential
of H. perforatum extracts has been somewhat neglected.
St. John’s wort medicinal properties, namely those re-
garding the antidepressant activity, have been related to
their phenolic composition and particularly hypericins,
hyperforins and flavonoids (Butterweck, 2003). H. per-
foratum ethanolic extracts contain many phenolic
compounds, namely flavonoids and phenolic acids,
suggesting that they could have important antioxidant
properties.
Data on the antioxidant properties of H. perforatum
extracts are scarce. Previous reports indicate that these
extracts show significant scavenging capacity for the
superoxide radical, produced by the xanthine/xanthine
oxidase system (Hunt, Lester, Lester, & Tackett, 2001).
Nevertheless, no correlation between these properties
and the phenolic composition of the extracts has been
investigated. The aim of this study was to evaluate an-
tioxidant potential of several H. perforatum extracts and
to determine its relationship with the phenolic compo-
sition, by analytical procedures.2. Materials and methods
2.1. Compounds
Chlorogenic acid, quercetin, rutin, DPPH, BHT, a-
tocopherol (Trolox) and thiobarbituric acid were pur-
chased from Sigma (Barcelona, Spain). Hyperoside,
isoquercetin, kaempferol, amentoflavon, and hypericin
were obtained from Extrasynthese (Genay, France).
Hyperforin tetramonium salt was a gift from Dr. Cle-
mans Erdelmeier (Wilmar Schwabe GmbH, Germany).
Sephadex LH-20 resin was supplied by Pharmacia
(Uppsala, Sweden). All other reagents were of analytical
grade and supplied by Merck (Darmstadt, Germany).2.2. Plant material and production of extracts of H.
perforatum
H. perforatum plants (flowers, including approx. 7 cm
of stem) were collected in the region of Braga, North of
Portugal, and the biomass was freeze-dried on the same
day. An ethanolic extract was prepared by extraction of
the biomass (100 mgdwb/ml) with an ethanol-water
solution (80:20). The mixture was filtered through a
paper filter (Whatman, No. 1) and the resulting total
ethanolic extract of H. perforatum (TE) was stored in a
dark glass bottle for further processing.
An aliquot of TE was sequentially fractionated by li-
quid–liquid extraction with hexane, ethyl acetate, and
butanol. The hexane, ethyl acetate and butanol extracts
were evaporated, separately, under reduced pressure, at
35 C in darkness. Hexane and butanol extracts residues
were named, respectively, fractions V1 and V6. The ethyl
acetate residue was dissolved in methanol and fraction-
ated over Sephadex LH-20 (column: 40 3 cm), using
methanol as eluent. The extracts resulting from column
elution were analysed by TLC, grouped according their
chemical composition, and evaporated under reduced
pressure, as described above, resulting in the fractions
V2–V5. TLC was performed on silica gel aluminium
plates using three different eluents for each sample.
Eluents utilised were ethyl acetate:formic acid:glacial
acetic acid:water (100:11:11:27), toluene:chloroform:ac-
etone:formic acid (40:25:35:1), and toluene:ethyl ace-
tate:formic acid (6:4:1). The aqueous extract remaining
from the sequential liquid–liquid extraction of TE was
lyophilised, resulting in a pale-cream powder named
fraction V7. All fractions were dissolved in ethanol, and
a small aliquot was taken for HPLC analysis. The re-
maining material was stored at )80 C, under a nitrogen
atmosphere, prior to further experiments.
2.3. Phenolic identification and quantification
TE and fractions were analysed by HPLC–DAD as
described previously (Dias, Seabra, Andrade, & Ferre-
ira, 1999). Chromatograms were recorded at 260, 350
and 590 nm. The quantification of the constituents was
done by the external standard method, using a solution
containing 15 lg/ml of each reference compound in
methanol. The reference compounds were chlorogenic
acid, rutin, hyperoside, isoquercitrin, quercetin, ka-
empferol, amentoflavone, hypericin and hyperforin salt.
Flavonols, flavones and caffeoylquinic acids were
quantified at 350 nm, hyperforins at 260 nm and hyp-
ericins at 590 nm. Other flavonols and cinnamic acid-
type compounds were quantified at 350 nm, as quercetin
and chlorogenic acid equivalents, respectively. Adhy-
perforin and hypericins were quantified at 260 and 590
nm, as hyperforin and hypericin equivalents, respec-
tively. All the samples were analysed in triplicate.
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HPLC–MS–MS. Chromatographic separation was car-
ried out on an RP C18 column (25 0.4 cm, particle size
5 lm, Merck, Germany), using water/formic acid (99:1)
and methanol as the mobile phases. Elution was per-
formed as described elsewhere (Dias et al., 1999). The
HPLC system was an Agilent HPLC 1100 instrument
series equipped with an Agilent DAD detector (G1315B,
Agilent Technologies, Germany) and mass detector in
series, controlled by software from Agilent Technologies
(Germany). The mass detector was an ion-trap mass
spectrometer (G2445A, Agilent Technologies, Ger-
many) equipped with an electrospray ionization (ESI)
system. The heated capillary and voltage were main-
tained at 350 C and 4 kV, respectively. The nebulizer
pressure and flow rate of nitrogen were 65.0 psi and 11 l/
min, respectively. Mass scan (MS) and daughter (MS–
MS) spectra were measured from 100 au to m/z 1500.
Collision-induced fragmentation experiments were per-
formed in the ion trap using helium as the collision gas,
with voltage ramping cycles from 0.3 up to 2 V. Mass
spectrometry data were acquired, both in the negative
and positive modes.
2.4. Free radical-scavenger activity
The free radical-scavenger activity was determined by
the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay, as de-
scribed previously (Silva & Dias, 2002). The antiradical
activity of each fraction was evaluated using a dilutions
series, in order to obtain a large spectrum of sample
concentrations. Additionally, the relative free radical-
scavenging activity was assessed using fractions with
equivalent dry-weight biomass concentrations. The re-
action solution consisted of 0.1 ml of sample and 1.4 ml
of a DPPH stock solution (80 lM, ethanol 100%). The
absorbance was monitored continuously at 515 nm with
a Perkin–Elmer UV/VIS Spectrometer Lambda2, as-
suring that the reaction was complete (plateau state).
Ethanol was used as a blank and trolox (0.5 mg/ml) was
used as a positive control. All determinations were
performed in triplicate.
The percentage of reduced DPPH at steady state
(DPPH R) was calculated and these values were plotted
against the log10 of the concentrations of individual
fractions. A decrease by 50% of the initial DPPH con-
centration was defined as the EC50. The amount of re-
duced DPPH was estimated for the first 5 min of
reaction for each fraction, at the dilution factor closest
to the estimated value EC50. These values were con-
verted to a ratio by dividing them by total DPPH re-
duced at the steady state. This ratio was named
reduction index (RIt50), a kinetic parameter that mea-
sures the velocity of the reaction of DPPH reduction. All
the parameters were calculated graphically using the
software GraphPad 4.0 (Prism, USA).2.5. Evaluation of lipid peroxidation – TBARS assay
The extent of lipid peroxidation was evaluated by
measuring the production of TBARS in the cortical
synaptosomes of male Wistar rat brains (1.5 months
old). The synaptosomal fraction was isolated as previ-
ously described (Silva, Carvalho, Carvalho, & Malva,
2001). The thiobarbituric acid assay was performed as
described elsewhere (Pereira, Moreira, Seica, Santos, &
Oliveira, 2000), with minor modifications. The synap-
tosomal fraction was diluted to obtain a final concen-
tration of 0.5 mg protein/ml. Lipid peroxidation was
assayed after incubation of synaptosomes with 800 lM
ascorbic acid and 2.5 lMFeSO4, in a final volume of 1.2
ml of Krebs buffer (132 mM NaCl, 4 mM KCl, 1.4 mM
MgCl2, 1 mM CaCl2, 6 mM glucose, 10 mM Hepes–Na,
pH 7.4), at 37 C for 15 min, in the presence of H.
perforatum fractions, with equivalent dry-weight bio-
mass. Controls were made with synaptosomes, without
the oxidant pair. BHT (0.45 mM, ethanol 100%) was
used as a positive control. The colour of the (MDA)–
TBA complex was detected at 530 nm, after reaction of
samples with TCA (40%, w/v) and TBA (0.67%, w/v)
(100 C, 10 min) and centrifugation (3000g, 10 min). The
amount of MDA formed was calculated using the ab-
sorption coefficient of 1.56 105 cm2/mol. Values were
corrected for the levels of basal peroxidation, obtained
during the assay.
The percentage of inhibition of lipid peroxidation
(after 15 min of reaction) was calculated as the reduction
in the levels of lipid peroxidation induced by the oxidant
pair, after correction for the basal levels (here consid-
ered as 100%). These values were plotted against the
log10 of the concentrations of individual fractions. A
decrease by 50% of the value of lipid peroxidation, in-
duced by ascorbate/Fe2þ, was defined as the EC50.
2.6. Statistical analysis
All data was analysed statistically with Statistica/Mac
software (Prism, USA). Mean differences were analysed
statistically by running a one way analysis of variance
test (ANOVA). The homogeneity of variance was tested
by Cochran’s test. Post-hoc comparisons were made
with the HSD Tukey test.3. Results and discussion
3.1. Fractionation and phenolic composition of the
extracts
Several papers have reported the analysis of H. per-
foratum extracts. However, most of them focus only on
some individual compounds, such as the hypericins or
the phloroglucinols; LC–MS studies were also done
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Uusitalo, Hohtola, & Jalonen, 2002). In this work, we
fully analysed the TE by HPLC–DAD and HPLC–
DAD–MS–MS and the major compounds were identi-
fied and characterised. Phenolic compounds were
identified by their UV spectra and by their MS spectra,
and their corresponding daughter MS/MS fragments.
TE was composed of a complex mixture of compounds
(Fig. 1), most of them already known to be present in H.
perforatum extracts (Dias et al., 1999; Erdelmeier et al.,
2000; J€urgenliemk & Nahrstedt, 2002), and two com-
pounds being identified for the first time in H. perfora-
tum extracts. Table 1 shows the MS data obtained by
LC–MS of the most representative phenolics present in
TE.
Compounds 1, and 3 have similar UV-spectra, char-
acteristic of chlorogenic-type acids, and have the same
deprotonated molecular ion (353.3, m/z), indicating that
they are isomers. These compounds were identified as
3-O-caffeoylquinic and 5-O-caffeoylquinic acids, re-
spectively, according with these described elsewhere
(Dias et al., 1999). HPLC–MS data confirmed the
identification. Compound 2 is a derivative of p-coumaric
acid accordingly to its UV–Vis and MS data. Probably,
it corresponds to 3-O-p-coumaroyl quinic acid, a com-
pound already detected in H. perforatum extracts
(J€urgenliemk & Nahrstedt, 2002).
A major group of compounds was identified as
flavonols, due to their characteristic UV spectra. Com-
pounds 4 and 5 have UV-spectra characteristic of
flavonols glycosylated at C3 (257, 265sh, 355 nm).
Compound 4 has a molecular ion m/z [M–H] of 609.0,
and its -MS2 [M–H] gave a single ion at m/z 300.4
(Table 1), indicating that it is a quercetin derivative with
a rhamnoglucoside at C3. The absence of intermediate
fragmentation between the deprotonated molecular ion
and the aglycone ion is indicative of an interglycosidic
linkage 1! 6 (Cuyckens, Rozenberg, Hoffmann, &
Claeys, 2001); therefore this compound was putatively
identified as rutin. Compounds 5 has a molecular ion
m/z [M–H] of 462.9, and its -MS2[M–H] gave an ion at
m/z 300.4 (Table 1), indicating that this compound is a
quercetin derivative with a hexose at C3, probably
hyperoside. The utilization of rutin, hyperoside com-
mercial standards confirmed the identification of com-
pounds 4 and 5. Compounds 7 and 8 shared the same
UV-spectra, similar to those observed for flavonols 4
and 5. Both compounds have a similar deprotonated
molecular ion m/z at 477.3 and a major -MS2 fragment
at m/z 300.5, corresponding to the loss of a glucuronic or
a galacturonic acid residue (Table 1). Therefore, these
compounds were identified as quercetin 3-glucuronate
and quercetin 3-galacturonate, respectively. Compound
9 has an UV-spectrum (255, 265sh, 301sh, 349) and MS
data consistent with those of quercetin 3-rhamnoside.
The identification was confirmed by spiking with acommercial standard of quercetin 3-rhamnoside and
confirmation of its MS data. Compound 10 was identi-
fied as a kaempferol derivative, due to its characteristic
UV-spectra (267, 297sh, 349 nm), with substitution at
position 3. The -MS and -MS2 spectra were consistent
with the presence of a rutinoside residue (Cuyckens
et al., 2001), and confirm the kaempferol aglycone, this
compound being identified as kaempferol 3-rutinoside.
Compound 11 hold a similar UV-spectrum to those of
compounds 4, 5, 6 and 7, indicating its quercetin 3-de-
rivative nature. It has a deprotonated molecular ion at
m/z 505.2 and a -MS2 fragment with an m/z of 462.7
(quercetin 3-galactoside/glucoside), that results from the
loss of an acetyl group. Moreover, an intense deproto-
nated ion of the aglycone was observed (m/z 300.2).
According to its UV and mass spectra this compound is
an acetyl derivative of hyperoside or isoquercitrin,
probably quercetin-3-O-(200-acetyl)-b-D-galactoside, a
compound recently identified in H. perforatum extracts
(J€urgenliemk & Nahrstedt, 2002). Compound 12 had a
similar UV-spectrum to compounds 5 and 11, a [M–H]
ion at m/z 651.7, and -MS2[M–H] ions at m/z 608.6
(M–H-Acetyl), corresponding to the loss of an acetyl
group from the deprotonated molecular ion, and at m/z
300.2, indicating its rutin-derivative nature. Compounds
10 and 12 are now reported for the first time in H.
perforatum extracts. Compound 13 has a UV-spectrum
(255, 265sh, 370 nm) and MS data consistent with those
of quercetin. The identification was confirmed by
spiking with a commercial standard of quercetin and
confirmation of its MS data. Compound 15 has a UV-
spectrum (268, 333 nm), similar to that of amentoflav-
one, and a [M–H] ion at m/z 537.4. These data and its
localization in the chromatogram are compatible with
biapigenin.
The compounds 17–20 were identified as hypericins
according to their characteristic UV–Vis spectra (Kurth
& Spreemann, 1998). Confirmation of hypericin identity
was supported by MS data consistent with that already
published (Tolonen et al., 2002). Hyperforin and adhy-
perforin were identified as described elsewhere (Dias &
Ferreira, 2003), and MS data agreed with published
reports (Fuzzati et al., 2001; Tolonen et al., 2002).
The fractions of H. perforatum were separated by
chromatographic procedures and the compounds pres-
ent in each fraction were identified and quantified by
HPLC–DAD and HPLC–MS. The results of quantita-
tive analysis by HPLC–DAD are presented in Table 2.
These results were expressed in H. perforatum biomass
equivalents since, in this way, all the fractions were
easily compared with the TE.
All compounds identified in the TE were specifically
concentrated in the individual fractions: fraction V1
contains derivatives of acylphloroglucinols, mainly hy-
perforin; fraction V2 contains hypericin and some re-
lated compounds (bianthraquinones); fraction V3 is
Fig. 1. HPLC chromatogram of H. perforatum total ethanolic extract (TE). Compounds are identified in the figure by numbers: 1 – neochlorogenic
acid (3-O-caffeoylquinic acid); 2 – caffeoylquinic acid type; 3 – chlorogenic acid (5-O-caffeoylquinic acid); 4 – rutin (quercetin-3-O-rutinoside);
5 – hyperoside (quercetin-3-O-b-D-galactoside); 6 – isoquercetin (quercetin-3-O-b-D-glucoside); 7 – quercetin 3-O-b-D-galacturonic; 8 – quercetin 3-
O-b-D-glucuronic; 9 – quercitrin (quercetin 3-O -a-L-rhamnoside); 10 – kaempferol 3-O-b-D-rutinoside; 11 – hyperoside-acetyl; 12 – rutin-acetyl;
13 – quercetin; 14 – kaempferol; 15 – biapigenin; 16 – amentoflavone; 17 – protopseudohypericin; 18 – pseudohypericin; 19 – protohypericin; 20 –
hypericin; 21 – hyperforin; 22 – adhyperforin.
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glycosides, the former occurring in higher amounts;
fraction V4 is composed solely of flavonol glycosides,
mainly of the quercetin-type; fraction V5 is composed offlavonoid aglycones, namely quercetin and biapigenin;
fraction V6 is composed of caffeoylquinic acids and
glycosides of flavonoids, with the latter occurring
in higher amounts; fraction V7 contains several
Table 1
HPLC–MS–MS data of the major identified compounds of H. perfo-
ratum
Compound [M–H] (m/z) –MS2 [M–H] (m/z) Rt (min)
1 353.3 5.25
2 337.1 6.20
3 353.3 6.88
4 609.0 300.4 17.95
5 462.9 300.4 18.15
7 477.2 300.5 18.58
8 477.3 300.5 19.54
9 446.6 300.3 19.93
10 593.5 284.4 20.92
11 505.2 462.7, 300.2 22.87
12 651.7 608.6, 590.5, 300.2 23.22
13 302.6a 24.35
15 537.4 442.5, 384.7 28.68
17 521.3 423.1 42.91
18 519.1 487.4, 421.2 45.96
19 505.3 407.2 51.36
20 503.3 405.3 56.80
21 535.2 383.1 61.59
22 549.9 397.3 62.36
Rt – retention time in high-precision liquid chromatography;
compound numbers correspond to those indicated in Fig. 1.
a Ion obtained in the positive mode, corresponding to the proton-
ation [M+H]þ.
162 B.A. Silva et al. / Food Chemistry 90 (2005) 157–167compounds of different phenolic classes, present at low
concentrations.
The results indicate that the fractionation process
resulted in extracts that, in global terms, contained
similar amounts of the compounds present in the ori-
ginal extract (TE) (Table 2). A significant exception was
observed for hypericins. The amount of pseudohypericin
found in fraction V2 was lower than that observed in the
TE. This could be due to a selective absorption of
pseudohypericin on the Sephadex resin.
3.2. Antioxidant properties of H. perforatum extracts
In this work, the antioxidant activities of TE and
isolated fractions were examined by two model systems,
the DPPH method and the inhibition of lipid peroxi-
dation in synaptosomes.
DPPH is a useful reagent for investigating the free
radical-scavenging activities of phenolic compounds
(Lebeau et al., 2000). The reduction of DPPH absorp-
tion is indicative of the capacity of the extracts to
scavenge free radicals, independently of any enzymatic
activity. The extraction methods resulted in different
extracts, with diverse compositions, either in qualitative
or quantitative terms (Table 2). We chose to normalize
the results in terms of plant dry weight biomass equiv-
alents, so that the TE and all fractions could be related
to the biomass used, making it easier to compare the
relative importance and potency of each fraction for
scavenging the DPPH radical. TE and all fractionspromoted the reduction of DPPH (Table 3). The best
free radical-scavenger activity was reported for the TE
and fractions V4 and V6, with EC50 values of 21, 80 and
82 g dwb/ml, respectively (Table 3). The lowest activity
was observed for fraction V7. This fraction resulted
from the aqueous extract, that remained after the se-
quential extraction of the TE with organic solvents (see
Materials and methods), being a very dilute fraction in
terms of compounds per biomass equivalents (Table 2).
This can justify the low activity registered for this frac-
tion. Trolox, used as a positive control in this assay,
exhibited the highest antiradical activity (EC50¼ 2.2
g compound/ml). However, it noteworthy mentioned
that the trolox EC50 value is for a pure compound,
whereas the values for the TE and fractions were ex-
pressed in amounts of dry weight biomass.
The EC50 is a parameter, widely used, that describes
ability of a compound or extract to scavenge the DPPH
radical. However, the EC50 values give little information
about the kinetics of a reaction, in terms of velocity
(Lebeau et al., 2000). Therefore, we used an additional
parameter, the reduction index (RIt50), to complement
the information (Table 3). This parameter gives an idea
of the reactivity of each fraction in bleaching the DPPH
free radical. All fractions induced a moderate decrease
in the concentration of DPPH (when compared with
trolox reactivity). The most reactive were the TE and
fractions V3–V6, exhibiting similar RIt50 values, al-
though with significantly different EC50 values (Table 3).
It is interesting to note that all these extracts possessed
high reactivity and had an important flavonoid com-
ponent (namely fractions V4 and V5). Fraction V7 ex-
hibited the weakest reactivity, significantly different
from any other extract, in spite of having a considerable
proportion of flavonoids and caffeoylquinic-type acids.
This low reactivity could be related to the presence of
other compounds (e.g. sugars, amino acids), not de-
tected by the HLPC procedures, that could somehow
interfere in the total reactivity of the fraction.
We evaluated the extent of lipid peroxidation using
the MDA formation as an index of breakdown of
membrane lipids, after incubation of rat cortical syn-
aptosomes with the oxidant pair ascorbate/Fe2þ. Brain
homogenate is useful for the investigation of lipid per-
oxidation and assessment of oxidative stress. Ferrous
ion stimulates lipid peroxidation of brain homogenate
through various mechanisms, for example through the
decomposition of lipid peroxides, the generation of hy-
droxyl radicals, or by formation of perferryl or ferryl
species (Ko, Cheng, Lin, & Teng, 1998).
Lipid peroxidation was assessed in the presence of H.
perforatum total ethanolic extract (TE). Fig. 2 shows the
protection conferred by increasing concentrations of
TE, in lipid peroxidation induced by ascorbate/Fe2þ in
rat cortical synaptosomes. TE reduced lipid peroxida-
tion in a dose-dependent manner, and proved to be an
Table 3
Free radical-scavenger activity (EC50) and initial reduction kinetics
(RIt50) of H. perforatum total ethanolic extract (TE) and fractions
Sample EC50 (lg dwb/ml) RIt50
Total extract (TE) 21 0.68a
V1 290 0.54b
V2 507 0.60b
V3 406 0.71a
V4 80a 0.67a
V5 145 0.68a
V6 82a 0.70a
V7 870 0.36
Trolox 2A 0.94
Values are mean means of six independent replicates. In each col-
umn, the values were statistically different ðP < 0:05Þ, except those
with the same letter.
A The EC50 values were calculated in terms of dry weight biomass
with the exception of trolox, calculated as the amount of pure com-
pound.
Table 2
Phenolic composition of H. perforatum extract (TE) and fractions (HPLC–DAD and HPLC–DAD–MS analysis)
Compound Fraction (g compound/g dwb)
TE V1 V2 V3 V4 V5 V6 V7
Phloroglucinols
Hyperforin 7400 6569
Adhyperforin 1470 1070
Total 8870 7639
Naphthodianthrones
Hypericin 620 871 Tr
Pseudohypericin 839 62 Tr
Protopseudohypericin 79 53
Protohypericin 80 56
Total 1618 1042
Phenolic acids
Neochlorogenic acid 1880 1002 538 277
Chlorogenic acid 1181 745 330 45
Unindentified 189 103 50 Tr
Total 3250 1850 918 322
Flavonol glycosides
Hyperoside+Rutin 5861 625 4050 871 290
Isoquercitrin 2442 188 1589 539
Quercetin 3-glucuronate
+Quercetin 3-galacturonate
222 170 23 10
Hyperoside-acetyl 888 83 786 21 20
Rutin-acetyl 133 98 Tr Tr
Kampferol 3-rutinoside 225 160 65
Quercetin 3-rhamnoside 3159 97 2835 126 60
Total 12,930 993 9688 1645 320
Flavonoid aglycones
Quercetin 4084 3960 Tr
Kaempferol 256 205 Tr
Biapigenin 1004 934 Tr
Amentoflavone 58 Tr
Total 5402 5099
Total phenolics 32,070 7639 1042 2843 9688 5099 2563 702
Tr – compounds at trace levels, detected only by HPLC–MS/MS.
Fig. 2. Inhibitory effect of H. perforatum total ethanolic extract (TE)
on lipid peroxidation induced by the oxidant pair ascorbate/Fe2þ, in
rat cortical synaptosomes. The oxidant pair increased basal levels of
peroxidation by approximately 15-fold. Values are means  SD of six
independent replicates.
B.A. Silva et al. / Food Chemistry 90 (2005) 157–167 163effective antioxidant. The EC50 value, determined for the
TE inhibitory effect on lipid peroxidation, was 26
lg dwb/ml. This value is in the same range as thatobserved for the TE scavenger activity of DPPH
(Table 3).
In order to evaluate the relative contribution of each
fraction to the total antioxidant activity of the TE (that
164 B.A. Silva et al. / Food Chemistry 90 (2005) 157–167represents the sum of all fractions), we evaluated the free
radical-scavenging activity (Table 4) and lipid peroxi-
dation inhibition (Table 5) of all fractions on an
equivalent plant biomass concentration basis. Fractions
V5, V6, and V4, composed of flavonol glycosides,
showed the highest free radical-scavenging activity and
contributed most of the activity of the TE.
The most effective fraction in protecting synapto-
somes from lipid peroxidation was V5, that contained
flavonoid aglycones (Table 5). At concentrations of 0.1
mg dwb/ml, fraction V5 exhibited a similar potency (in
reducing lipid peroxidation), to the TE. Fractions V3,
V5, and V6 were able to inhibit lipid peroxidation, with
similar efficacy to the TE, only at concentrations of 2
mg dwb/ml. Fractions V1 and V2, containing respec-
tively hyperforins and hypericins, were ineffective in
reducing lipid peroxidation, at all concentrations tested
(Table 5).
Among the fractions tested, fractions V4 and V5,
composed basically of quercetin glycosides and agly-
cones, respectively, contributed mainly to the TE anti-
oxidant activity (Tables 4 and 5). Fraction V4 had a
stronger free radical-scavenging activity, whereas frac-Table 5
Inhibition of lipid peroxidation (%) of H. perforatum total ethanolic extract
Sample Equivalent biomass concentration (mgdwb/m
0.03 0.1
TE 52.7 6.59 91.6 2.07c
V1 0.0 1.04ac 0.1 0.12ad
V2 0.0 2.00ac 0.0 0.29ad
V3 0.0 3.50ac 3.1 2.00ae
V4 0.0 2.15ac 3.6 2.99ae
V5 2.2 5.06c 98.9 5.51ac
V6 0.0 5.08ac 0.0 4.37ad
V7 0.0 2.53ac 0.0 0.21ad
Lipid peroxidation is shown as percentages of reduction, relatively to the
increased basal levels of peroxidation by approximately 15-fold. Values are m
are statistically different ðP < 0:05Þ except those marked with the same letter
those marked with the same symbol.
Table 4
Relative antiradical activity of H. perforatum total ethanolic extract (TE) an
Equivalent biomass concentration (mgdwb/ml)
0.010 0.015 0.025 0.050 0.075
TE 0.0 37.6 55.4 74.2 80.8
V1 1.7a 1.7a 1.7a 1.7a 1.8a
V2 5.5a 5.5a 5.5a 5.5a 5.5a
V3 2.6a 2.7a 2.7a 3.0ab 3.2b
V4 12.5a 12.5a 12.5a 12.6a 12.8a
V5 3.6a 3.7a 3.7a 4.0ab 4.4bc
V6 5.5a 5.6a 5.6a 5.9ab 6.2bc
V7 8.0a 8.1a 8.1a 8.1a 8.1a
Sum 39.3a 39.6a 39.8a 40.7ab 42.0bc
Values are in percentages of DPPH reduction and are means of six ind
ðP < 0:05Þ except those marked with the same letter.
* The row with an asterisk shows the sum of the DPPH reductions of alltion V5 was more effective in protecting against lipid
peroxidation. In general, the substitution of hydroxyl
groups by glycosylation decreases the antioxidant ac-
tivity of a phenolic compound (Rice-Evans, Miller, &
Paganga, 1997). Specifically, glycosylation resulted in
lower antioxidant activity for quercetin using DPPH
(Fukumoto & Mazza, 2000). Addition of a sugar moiety
decreases activity of the aglycone, probably due to steric
hindrance. Also, Cos et al. (2001), using a lipid peroxi-
dation model in rat liver microsomes, observed that
quercetin had lower IC50 values than its glycosylated
derivatives quercitrin and rutin. This is in accordance
with the higher lipid peroxidation inhibition observed
for fraction V5. However, this does not explain the
higher free radical-scavenging activity of fraction V4
than V5. Fraction V4 had a significantly higher amount
of total flavonoids (almost 2-fold) than fraction V5
(Table 2). Therefore, in this case the free radical-scav-
enging effect measured would be more influenced by the
high quantity of flavonols present in fraction V4, rather
than by the structural characteristics of the compounds.
In the lipid peroxidation model, besides the structural
effects, other factors, such as the hydrophobicity of the(TE) and fractions in lipid peroxidation
l)
2 10
95.2 0.57ac 95.0 0.07ac
0.1 2.37ad 0.0 0.15af
0.2 1.66ad 0.0 0.18af
97.9 1.07c 23.3 1.72de
97.8 0.38c 75.4 6.67
100.8 0.20bc 99.5 1.35abc
96.7 0.89c 27.7 1.66d
48.6 6.65 20.2 5.68e
levels obtained with the oxidant pair ascorbate/Fe2þ. The oxidant pair
eans  SD of three to six independent replicates. In each row, all values
. In each column, all values are statistically different ðP < 0:05Þ except
d fractions
0.100 0.150 0.250 0.500 1.500
83.8 86.4a 88.1ab 89.1b 89.5b
1.9ab 2.1b 2.7 5.3 24.3
5.5a 5.5a 5.6a 6.2 11.6
3.5b 4.1 5.5 9.0 23.2
13.1ab 14.0b 17.1 30.0 71.5
4.8c 5.8 8.3 16.1 46.0
6.7c 7.8 10.6 20.1 54.1
8.1a 8.2a 8.3ab 8.7b 11.5
43.5c 47.4 58.1 95.6 242
ependent replicates. In each row, all values are statistically different
fractions, except TE, for a given equivalent biomass.
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Rego, Oliveira, & Seabra, 2001). The higher efficiency of
flavonoid aglycones in lipid systems, relatively to their
glycoside counterparts, is mainly due to their lower
polarity and higher partition coefficient (Schroeter,
Williams, Matin, Iversen, & Rice-Evans, 2000). There-
fore, the aglycones present in fraction V5 would have a
higher ability to interact with the synaptosomal mem-
branes, thus being more effective in preventing lipid
peroxidation than quercetin glycoside derivatives, com-
pounds with a more hydrophilic character.
At high biomass equivalents concentrations (10
mg dwb/ml), fractions V3, V4, V6, and V7, exhibited a
pro-oxidant behaviour, shown by decreased efficiency in
inhibiting lipid peroxidation (Table 5). A seemingly pro-
oxidant effect was also observed in a cell-free system,
using the xanthine/xanthine oxidase system, when an H.
perforatum extract was tested at high concentrations
(Hunt et al., 2001). In our case, the TE did not show any
pro-oxidant effect at the concentrations tested, for either
antioxidant model (Tables 4 and 5). Some phenolics are
capable of redox cycling of the metal ion required for
hydroxyl generation, thus increasing the radical pro-
duction and exhibiting a pro-oxidant activity (Li & Xie,
2000; Miranda et al., 2000). Valentao et al. (2002) ob-
served that an H. androsaemum lyophilised infusion was
an effective substitute for ascorbic acid, when at high
concentrations and that it could act as a pro-oxidant.
Hunt et al. (2001) evaluated the antioxidant effect of
preparations of H. perforatum extracts against the su-
peroxide anion. They observed a free radical-scavenging
effect for most of the concentrations tested and postu-
lated that this effect could be related to its content in
hypericin, among other compounds. Our results dem-
onstrated that compounds other than hypericins should
be relevant for this activity. Taking in account the ac-
tivity of the H. perforatum fractions tested, the hy-
droxycinnamic acids and flavonoids were highly relevant
for both radical-scavenging and inhibition of lipid per-
oxidation activities (Tables 3–5). Conforti, Statti, Tun-
dis, Menichini, and Houghton (2002) evaluated the
antioxidant potential of H. triquetrifolium Turra in a
lipid peroxidation assay. In accordance with our results,
they observed that the antioxidant activity of this species
could be related to the content of flavonoids. The anti-
oxidant activity of an H. androsaemum infusion was also
related to its phenolic content (Valentao et al., 2002).
Some of the identified phenols in the H. androsaemum
infusion extract were 3- and 5-O-caffeoylquinic acids,
quercetin and glycosylated derivatives, also present in
extracts of H. perforatum. Flavonoids, specifically
quercetin and its glycoside derivatives, are a major class
of compounds present in the H. perforatum total eth-
anolic extract (TE), representing almost 57% of the total
phenols present in TE, whereas hydroxycinnamates
represent up to 10% (Table 2). These types of com-pounds are well known antioxidants. They have struc-
tural aspects, such as the presence of a catechol moiety
in the ring, a 2,3-double bond in conjunction with a
4-oxo group in the C-ring, and the presence of hydroxyl
groups at positions 3 and 5, which are all determinants
of high antioxidant activity (Halliwell, Aeschbach,
L€oliger, & Aruoma, 1995; Rice-Evans et al., 1997).
The observed antioxidant properties of the total
ethanolic extract of H. perforatum could be, in part,
responsible for some of the medicinal claims that are
attributed to this plant, namely those related to free
radical generation, such as the anti-inflammatory
properties. ROS have been proven to cause damage to
central nervous systems (Behl & Mosmann, 2002; Foy
et al., 1999; Hyun, Lee, Halwell, & Jenner, 2002;
Markesbery, 1997), so antioxidant properties of prod-
ucts that exert their effects in the CNS, such as H. per-
foratum extracts, could prove to be beneficial in
oxidative stress situations at this level. Recently, it was
reported that amentoflavone, also identified in our
study, is able to pass the blood–brain barrier by simple
diffusion (Gutmann et al., 2002). Also, utilizing an in
vitro model, it was shown that several dietary flavonoids
and their known physiologically relevant metabolites
were able to cross the blood–brain barrier (Youdim
et al., 2003). So, it seems plausible to assume that the
consumption of extracts of H. perforatum might be able
to exert a positive action in the CNS.4. Conclusions
In conclusion, the total ethanolic extract of H. per-
foratum (TE) possesses high antioxidant activities. The
consumption of TE and, certain fractions, either as
pharmaceutical preparations or included in food prod-
ucts, has the potential to confer antioxidant properties
with benefit to health. It seems that the use of H. per-
foratum extracts cause no apparent significant side ef-
fects in most consumers (Kasper, 2001). However, the
intake of these extracts together with some conventional
drugs, can lead to negative interactions, with undesir-
able consequences (LaFrance et al., 2000). More scien-
tific work has to be done in order to verify the
antioxidant effect of H. perforatum extracts in in vivo
conditions, and to ensure their effectiveness and absence
of adverse effects.Acknowledgements
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